-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

603. Lymphoid Oncogenesis: Basic: Poster II

Symposia: Lymphoid Oncogenesis: Basic Program: Oral and Poster Abstracts
Type: Poster
Sunday, December 11, 2022: 6:00 PM-8:00 PM
Hall D (Ernest N. Morial Convention Center)

Leo Meriranta, MD1*, Selma Sorri, MS2*, Sadia Zafar, PhD2*, Xiaonan Liu, PhD3*, Eerika Sahlberg, MD4*, Olli Dufva5*, Helka Göös, PhD3*, Marja-Liisa Karjalainen-Lindsberg, MD, PhD6*, Markku Varjosalo, PhD3*, Marko Hyytiäinen, PhD2* and Sirpa Leppa, MD, PhD1,7

1Research Programs Unit, Applied Tumor Genomics, Faculty of Medicine, University of Helsinki, Helsinki, Finland
2Research Programs Unit, Applied Tumor Genomics, University of Helsinki, Helsinki, Finland
3Institute of Biotechnology, HiLIFE, Proteomics Unit, University of Helsinki, Helsinki, Finland
4Faculty of Medicine, University of Helsinki, Helsinki, Finland
5Translational Immunology Research Program, University of Helsinki, Helsinki, Finland
6Helsinki University Hospital, Helsinki, Finland
7Department of Oncology, Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland

Joseph R. Krambs, BS1, Kimberly B. Johansson, BA2, Isabelle Genter, BS3*, Sai Mukund Ramakrishnan, MS4*, Christopher A Miller, PhD4* and Daniel C. Link, MD5

1Division of Oncology, Department of Medicine, Washington University School of Medicine, High Ridge, MO
2Medical Scientist Training Program, Washington University in St. Louis, Saint Louis, MO
3Washington University in St. Louis, Saint Louis, MO
4Department of Medicine/Division of Oncology, Washington University School of Medicine, Saint Louis, MO
5Department of Medicine/Division of Oncology, Washington University School of Medicine, St. Louis, MO

Guillaume P Andrieu, PhD1,2*, Mathieu Simonin, MD3*, Aurélie Cabannes-Hamy, MD4*, Etienne Lengline, MD5*, Ambroise Marçais, MD, PhD6*, Marie Emilie Dourthe, MD7,8,9*, Nicolas Boissel, MD, PhD10, Hervé Dombret, MD, PhD11, Philippe Rousselot, MD, PhD12*, Olivier Hermine, MD, PhD13 and Vahid Asnafi, MD, PhD3,14*

1Laboratoire d'Onco-Hématologie, Hôpital Necker-Enfants Malades, Assistance Publique-Hopitaux De Paris, Paris, France
2Assistance Publique-Hopitaux De Paris (AP-HP), Hopital Necker Enfants-Malades, Paris, France
3Institut Necker-Enfants Malades, INSERM U1151, Paris, France
4Hemato-Oncology Department, Andre Mignot Hospital, Le Chesnay, FRA
5Hematology Department, Saint-Louis Hospital AP-HP Paris France, Paris, France
6Hematology Department, Necker University Hospital, PARIS, France
7Laboratory of onco-hematology, UMR 1151, Institut Necker Enfants Malades, Université Paris Descartes Sorbonne cité, Paris, France
8Pediatric Hematology-Immunology Department, Hôpital Necker Enfants Malades, Paris, France
9Pediatric Hematology-Immunology Department, Robert Debré Hospital, APHP, Paris, France
10Hematology Adolescent and Young Adult Unit, France, Paris Cedex 10, France
11Division of Hematology, EA3518 Saint-Louis Institute for Research, Hôpital Saint-Louis, APHP, University of Paris, Paris, France, Paris, France
12Hematology Department, Centre Hospitalier de Versailles, LE CHESNAY CEDEX, France
13Department of Hematology, Necker Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France
14Laboratoire d'Onco-Hématologie, Hôpital Necker-Enfants Malades, Assistance Publique Hôpitaux de Paris (APHP), Paris, France

Hyoju Kim1*, Tze King Tan, PhD1*, Xiao Zi Huang1*, Jolynn Ong, PhD1*, Rui Yokomori, PhD1*, Allen Eng Juh Yeoh, MD2,3, Takaomi Sanda, MD, PhD1,4 and Shi Hao Tan, PhD1*

1Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore
2National University Children’s Medical Institute, National University Health System, Singapore, Singapore
3Division of Haematology-Oncology, Department of Paediatrics, National University Hospital Singapore, Singapore, Singapore
4Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore

Feng Yan, PhD1*, Cedric Tremblay, PhD1*, Francine Garret-Bakelman, M.D, Ph.D2*, Jesslyn Saw, BSc1*, Matthew P. McCormack, PhD3*, Shokoufeh Abdollahi, MS1*, Pieter Van Vlierberghe, PhD4, David Powell, PhD5*, Nicholas C. Wong, BSc (Hons) PhD5* and David J. Curtis, MBBS, PhD6

1Australian Centre for Blood Diseases, Monash University, Melbourne, Australia
2Department of Medicine and Department of Biochemistry and Molecular Genetics, University of Virginia, Charlottesville, VA
3iCamuno Biotherapeutics, Melbourne, Australia
4Cancer Research Institute Ghent (CRIG), Ghent, Flanders, Belgium
5Monash Bioinformatics Platform, Monash University, Melbourne, Australia
6Australian Centre for Blood Diseases, Monash University, Melbourne, VIC, Australia

Kohei Kume, PhD1*, Zhengshan Chen, MD-PhD2*, Lai N. Chan, PhD3, Mark E. Robinson, PhD3*, Etienne Leveille, MD3, Jaewoong Lee, PhD3*, Kadriye Nehir Cosgun, PhD3*, David Fonseca Arce3*, Dhruv Khanduja3*, Lars Klemm3* and Markus Müschen, MD3

1Center of Molecular and Cellular Oncology and Department of Immunobiology, Yale University, Duarte, CA
2Department of Pharmacology, Kaiser Permanente Riverside Medical Center, Riverside, CA
3Center of Molecular and Cellular Oncology and Department of Immunobiology, Yale University, New Haven, CT

Zunsong Hu, PhD1,2, Zhilian Jia, PhD3,4, Behzad Damirchi1,4* and Zhaohui Gu, PhD1,4

1Department of Computational and Quantitative Medicine, Beckman Research Institute of City of Hope, Duarte, CA
2Department of Systems Biology, Beckman Research Institute of City of Hope, Baldwin Park, CA
3Department of Computational and Quantitative Medicine, Beckman Research Institute of City of Hope, Arcadia, CA
4Department of Systems Biology, Beckman Research Institute of City of Hope, Duarte, CA

Sabrina A Smith, BSc1,2*, Laura Garcia Prat, PhD, BSc, MSc2, Mohsen Hosseini2*, Liqing Jin2*, Nathan Mbong2*, Monica Doedens2*, Jessica McLeod, BSc2*, Julie A. Reisz3*, Rebecca Wilkerson3*, Angelo D'Alessandro, PhD3, Steven M. Chan, MD, PhD4, Courtney L Jones, PhD2 and John E. Dick, PhD1,5

1Department of Molecular Genetics, University of Toronto, Toronto, ON, Canada
2Princess Margaret Cancer Centre; University Health Network, Toronto, ON, Canada
3Department of Biochemistry and Molecular Genetics, University of Colorado School of Medicine, Aurora, CO
4Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada
5Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada

Kelly R. Barnett, PhD1,2*, Jonathan D. Diedrich, PhD1,2*, Brennan P. Bergeron, MS1,2,3*, Wenjian Yang, PhD1,2*, Kristine R. Crews, PharmD1,2*, Wendy Stock, MD4, Elisabeth Paietta, PhD5*, Steven M. Kornblau, MD6, Hiroto Inaba, MD, PhD1,7, Sima Jeha, MD1,7, Ching-Hon Pui, MD1,7, Mary V. Relling, PharmD1,2, William E. Evans, PharmD1,2, Jun J. J. Yang, PhD1,8,9 and Daniel Savic, PhD1,2,3,8

1Hematological Malignancies Program and Center for Precision Medicine in Leukemia, St. Jude Children's Research Hospital, Memphis, TN
2Department of Pharmacy and Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, TN
3Graduate School of Biomedical Sciences, St. Jude Children's Research Hospital, Memphis, TN
4Comprehensive Cancer Center, University of Chicago Medicine, Chicago, IL
5Albert Einstein College of Medicine, New York, NY
6Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
7Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN
8Integrated Biomedical Sciences Program, University of Tennessee Health Science Center, Memphis, TN
9Department of Pharmacy and Pharmaceutical Sciences, St. Jude Children’s Research Hospital, Memphis, TN

Vera M Poort1,2*, Rico Hagelaar, MSc1,3*, Diego Montiel González, MSc1,3*, Jessica G.C.A.M. Buijs-Gladdines3*, Laurianne Trabut, MSc1,3*, Bram van Wijk, PhD4*, Jules PP Meijerink, PhD3,5 and Ruben Van Boxtel, PhD1,3*

1Oncode Institute, Utrecht, Netherlands
2Princess Maxima Center For Paediatric Oncology, Utrecht, Netherlands
3Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands
4Wilhelmina Children's Hospital (WKZ), University Medical Center Utrecht, Utrecht, Netherlands
5Acerta Pharma B.V., Oss, Netherlands

Amin Sobh, PhD1, Charlotte L Kaestner, BS1, Alberto Riva, PhD2*, Karthik Vasan3*, Alisha Patel1*, Greeshma Surapaneni1*, Janai Poullard1*, Elena Encinas1*, Richard Lynn Bennett, PhD1, Constantine S. Mitsiades, MD, PhD4, Lawrence H. Boise, PhD5, Navdeep S. Chandel, PhD3* and Jonathan D. Licht, MD1

1Department of Medicine, University of Florida, Gainesville, FL
2Interdisciplinary Center for Biotechnology Research, University of Florida, Gainesville, FL
3Northwestern University, Chicago, IL
4Dept. of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
5Emory University, Atlanta, GA

Xuxiang Liu, PhD1*, Kunal Shetty, BS1*, Yuping Li, Ph.D.1*, Jibin Zhang, Ph.D.1*, Alyssa C. Bouska, Ph.D.2*, Javeed Iqbal, Ph.D.2*, Giorgio Inghirami, MD3* and Wing C. Chan, MD1

1Department of Pathology, City of Hope National Medical Center, Duarte, CA
2Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE
3Weill Cornell Medicine, New York, NY

Rachel Wong1*, Samuel Gusscott, PhD1*, Gabriela Cristina Segat, MSc1*, Annaick Carles, PhD2*, Reanne Bowlby, MSc1*, Martin Hirst, PhD2* and Andrew P. Weng, MD3

1BC Cancer Agency, Vancouver, Canada
2University of British Columbia, Vancouver, Canada
3Terry Fox Laboratory, BC Cancer Agency, Vancouver, BC, Canada

Kota Yoshifuji, MD, PhD1*, Yotaro Motomura, M.D.1*, Makiko Saito, M.D.1*, Ayako Nogami, M.D., Ph.D.2, Genji Kawade3*, Shiori Watabe3*, Kouhei Yamamoto, M.D., Ph.D.3*, Takehiko Mori, M.D., Ph.D.1* and Toshikage Nagao, M.D., Ph.D.1*

1Department of Hematology, Tokyo Medical and Dental University (TMDU), Tokyo, Japan
2Department of Laboratory Medicine, Tokyo Medical and Dental University (TMDU), Tokyo, Japan
3Department of Comprehensive Pathology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University (TMDU), Tokyo, Japan

Junbin Huang1*, Jing Yang2*, Yun Chen, PhD3,4*, Zhizhuang Joe Zhao, PhD4,5 and Chun Chen, MD, PhD4*

1Sun Yat-Sen University, Shenzhen, China
2pediatric, the seventh affiliated hospital, Sun Yat-sen University, shenzhen, China
3Moores Cancer Center, University of California, San Diego, La Jolla, CA
4The Seventh Affiliated Hospital of Sun Yat-sen University, Shenzhen, China
5Department of Pathology, University of Oklahoma Health Sciences Center, Oklahoma City, OK

*signifies non-member of ASH